Suchergebnisse - "Abla, Nada"

PubPharm (59)

1

Randomized, placebo-controlled, double-blind phase I trial of co-administered pyronaridine and piperaquine in healthy adults of sub-Saharan origin

enthalten in: Clinical and translational science | 2024

von Kuemmerle, A. | Gossen, D. | Janin, A. | +7

2

Randomized, placebo‐controlled, double‐blind phase I trial of co‐administered pyronaridine and piperaquine in healthy adults of sub‐Saharan origin

enthalten in: Clinical and Translational Science | 2024

von Kuemmerle, A. | Gossen, D. | Janin, A. | +7

3

Development and application of a PBPK modeling strategy to support antimalarial drug development

enthalten in: CPT: pharmacometrics & systems pharmacology | 2023

von Abla, N. | Howgate, E. | Rowland-Yeo, K. | +15

4

Safety and efficacy of four drug regimens versus standard-of-care for the treatment of symptomatic outpatients with COVID-19 : A randomised, open-label, multi-arm, phase 2 clinical trial

enthalten in: EBioMedicine | 2022

von Chandiwana, N. | Kruger, C. | Johnstone, H. | +13

5

Combination of quinoline-4-carboxamides and benzonaphthyridine derivatives as antimalarial drug combination

enthalten in: Europäisches Patentamt | 2022

von SPANGENBERG THOMAS | OEUVRAY CLAUDE | ABLA NADA

6

Combination of quinoline-4-carboxamides and benzonaphthyridine derivatives as antimalarial drug combination

enthalten in: Europäisches Patentamt | 2022

von SPANGENBERG THOMAS | OEUVRAY CLAUDE | ABLA NADA

7

An innovative study design with intermittent dosing to generate a GLP-regulatory package in preclinical species for long lasting molecule M5717, inhibitor of Plasmodium eukaryotic translation elongation factor 2

enthalten in: Toxicology and applied pharmacology | 2022

von Hewitt, P. | Abla, N. | Lignet, F. | +3

8

Preclinical characterization and target validation of the antimalarial pantothenamide MMV693183

enthalten in: Nature communications | 2022

von de Vries, L. | Jansen, P. | Barcelo, C. | +42

9

Unanticipated CNS Safety Signal in a Placebo-Controlled, Randomized Trial of Co-Administered Atovaquone-Proguanil and Amodiaquine

enthalten in: Clinical pharmacology and therapeutics | 2022

von Chalon, S. | Chughlay, M. | Abla, N. | +5

10

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Coadministered Ruxolitinib and Artemether-Lumefantrine in Healthy Adults

enthalten in: Antimicrobial agents and chemotherapy | 2022

von Chughlay, M. | Barnes, K. | El Gaaloul, M. | +16

1
2
3
4
5
6
Nächster »
[6]